EVENTS 2011.
- Published in:
- 2010
- Publication type:
- Calendar
Works matching IS 14667401 AND DT 2010 AND VI 11 AND IP 2
Results: 28
1
2
43rd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN).
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
3
Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 86
- Publication type:
- Article
4
Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population based case--control study.
- Published in:
- 2010
- Publication type:
- Case Study
5
Clinical utility of measuring infliximab and human antichimeric antibody concentrations in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 85
- Publication type:
- Article
6
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 84
- Publication type:
- Article
7
Natural history of Crohn's disease: comparison between childhood and adult-onset disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 84
- Publication type:
- Article
8
Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 83
- Publication type:
- Article
9
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 83
- Publication type:
- Article
10
Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 82
- Publication type:
- Article
11
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 81
- Publication type:
- Article
12
Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 81
- Publication type:
- Article
13
Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 80
- Publication type:
- Article
14
Outcome following infliximab therapy in children with ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 80
- Publication type:
- Article
15
Inducible Foxp3<sup>+</sup> regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 79
- Publication type:
- Article
16
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 79
- Publication type:
- Article
17
Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 78
- Publication type:
- Article
18
p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 77
- Publication type:
- Article
19
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 77
- Publication type:
- Article
20
Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 76
- Publication type:
- Article
21
Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 76
- Publication type:
- Article
22
Dipeptidyl peptidase expression during experimental colitis in mice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 75
- Publication type:
- Article
23
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 74
- Publication type:
- Article
24
Faecal lactoferrin -- a novel test to differentiate between the irritable and inflamed bowel?
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 74
- Publication type:
- Article
25
Probiotics in IBD: A Critical Review.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 65
- By:
- Publication type:
- Article
26
Mesenchymal Stromal Cells in Crohn's Disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 57
- By:
- Publication type:
- Article
27
Environmental Triggers of IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 49
- By:
- Publication type:
- Article
28
Professor Marc Lémann President of GETAID 1956-2010.
- Published in:
- 2010
- By:
- Publication type:
- Biography